789 PRECLINICAL CHARACTERIZATION OF NOVEL CYCLOPHILIN INHIBITORS BASED ON THE POLYKETIDE, SANGLIFEHRIN
Steven J. Moss, Matthew A. Gregory, Tony Warneck, Antje Habel(German Cancer Research Center), Michael Bobardt(Scripps Research Institute), Mohammad Nur‐e‐Alam, Pieter Leyssen(Rega Institute for Medical Research), Nigel Coates(Isomerase Therapeutics (United Kingdom)), Chris Martin(University of Sheffield), Jan Paeshuyse(Rega Institute for Medical Research), Philippe Gallay(Scripps Research Institute), Susan Obeid(Rega Institute for Medical Research), Teresa A. Foster, Johan Neyts(Rega Institute for Medical Research), D. Suthar, Udayan Chatterji(Scripps Research Institute), Steven G. Kendrew, Barrie Wilkinson(Norwich Research Park)
Cited by 0
Related Papers
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
|Science|1996|4.9k
HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
|Proceedings of the National Academy of Sciences|1997|483
HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase
|Cell|1995|355
Active Site Residues of Cyclophilin A Are Crucial for Its Signaling Activity via CD147
|Journal of Biological Chemistry|2002|338